Encompass Health (NYSE:EHC) reported its Q2 earnings results on Monday, August 1, 2022 at 04:00 PM.
Here’s what investors need to know about the announcement.
Earnings
Encompass Health missed estimated earnings by 8.25%, reporting an EPS of $0.89 versus an estimate of $0.97.
Revenue was up $43.00 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.05 which was followed by a 4.8% increase in the share price the next day.
Here’s a look at Encompass Health’s past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | 0.92 | 1.05 | 1.06 | 0.98 |
| EPS Actual | 0.97 | 0.97 | 1.03 | 1.17 |
| Revenue Estimate | 1.32B | 1.31B | 1.31B | 1.26B |
| Revenue Actual | 1.33B | 1.32B | 1.28B | 1.29B |
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Guidance
Encompass Health management provided guidance for FY 2022, expecting earnings between $2.77 and $2.91 per share.
To track all earnings releases for Encompass Health visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
